Robert J. Fram
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Cancer Treatment and Pharmacology
- Bone health and treatments
Papers in
-
- DNA Repair Mechanisms 10
- Cancer therapeutics and mechanisms 10
- DNA and Nucleic Acid Chemistry 8
- Histone Deacetylase Inhibitors Research 6
- Oncology 33
- Lung Cancer Research Studies 7
- Co-authors
- Donald Küfe (8 shared papers)D Kufe (3 shared papers)John M. Wilson (3 shared papers)Martin Marinus (5 shared papers)Edward A. Sausville (3 shared papers)Douglas V. Faller (16 shared papers)George Dover (1 shared paper)Barbara A. Conley (1 shared paper)
- Journals
- Journal of Clinical Oncology (15 papers)Blood (6 papers)Biochemical Pharmacology (4 papers)Leukemia Research (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesFranceJapan
In The Last Decade
Robert J. Fram
77 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 101
- Hematology 284
- Oncology 594
- Molecular Biology 900
- Cancer Research 181
- Genetics 90
Countries citing papers authored by Robert J. Fram
This map shows the geographic impact of Robert J. Fram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Fram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Fram more than expected).
Fields of papers citing papers by Robert J. Fram
This network shows the impact of papers produced by Robert J. Fram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Fram. The network helps show where Robert J. Fram may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert J. Fram, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. | 1998 | 137 |
| 2 | 2005 | 93 | |
| 3 | 1994 | 93 | |
| 4 | 2009 | 83 | |
| 5 | 2022 | 75 | |
| 6 | DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin. | 1982 | 70 |
| 7 | 1985 | 68 | |
| 8 | 1992 | 65 | |
| 9 | 2005 | 59 | |
| 10 | Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells. | 1990 | 57 |
| 11 | 2005 | 43 | |
| 12 | Antineoplastic effects of chemotherapeutic agents are potentiated by NM-3, an inhibitor of angiogenesis. | 2002 | 43 |
| 13 | 2005 | 42 | |
| 14 | 2012 | 37 | |
| 15 | 1984 | 36 | |
| 16 | 2001 | 34 | |
| 17 | 1983 | 34 | |
| 18 | 2005 | 33 | |
| 19 | 1986 | 33 | |
| 20 | 1985 | 31 |
About Robert J. Fram
Robert J. Fram is a scholar working on Molecular Biology, Oncology, Hematology, Genetics and Pulmonary and Respiratory Medicine, having authored 83 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (16 papers), Lung Cancer Treatments and Mutations (11 papers), DNA Repair Mechanisms (10 papers), Cancer therapeutics and mechanisms (10 papers), DNA and Nucleic Acid Chemistry (8 papers), Chronic Lymphocytic Leukemia Research (8 papers), Lung Cancer Research Studies (7 papers) and Histone Deacetylase Inhibitors Research (6 papers). The work is most often cited by research in Hematology (284 citations), Oncology (594 citations), Molecular Biology (900 citations), Cancer Research (181 citations) and Genetics (90 citations). Robert J. Fram has collaborated with scholars based in United States, France and Japan. Frequent co-authors include Donald Küfe, D Kufe, John M. Wilson, Martin Marinus, Edward A. Sausville, Douglas V. Faller, George Dover, Barbara A. Conley, Merrill J. Egorin and Nancy Tait. Their work appears in journals such as Journal of Clinical Oncology, Blood, Biochemical Pharmacology, Leukemia Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.